Epclusa is another hepatitis C direct-acting antiviral drug from the American company Gilead with sofosbuvir as the backbone. Patients with chronic hepatitis c must first undergo a systemic examination before taking Epclusa. Epclusa has little side effects but a high cure rate. You can check Epclusa cost here- https://www.medixocentre.com/epclusa-cost